
business
Pharmaceutical giant Pfizer to combine with Mylan
Pfizer is buying Mylan in an all-stock deal and combining the $10bn generic pharmaceutical company with its own off-patent branded and generic business.
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC